Passwords on the Rise Despite Evidence That They Are Increasingly Unable to Protect, Finds Thales
6.5.2020 09:00:00 EEST | Business Wire | Press release
According to the 2020 Thales Access Management Index – Europe and Middle East Edition 1 – nearly a third (29%) of organisations in Europe and the Middle East still see usernames and passwords as one of the most effective means to protect access to their IT infrastructure, two years after the inventor of the complex static password admitted they don’t work. In fact, 67% of respondents indicate that their organisations plan to expand its use of usernames and passwords in the future. This continued reliance on outdated security comes despite IT leaders revealing it is increasingly easier (48%) to sell the need for security to their boards compared to last year (29%).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200505005035/en/
(Photo: Thales)
Surveying 400 IT decision-makers across Europe and the Middle East, Thales’s new research found that the majority (57%) of IT professionals revealed that unprotected infrastructure is one of the biggest targets for cyber-attacks. Therefore any organization utilising it, as a result of business pressure driving them to adopt digital transformation technologies, are likely to be putting themselves at a higher level of risk.
Solving the Security vs. Convenience Conundrum
With the Covid-19 global pandemic causing many companies to work from home, IT departments are battling to provide employees with both security and convenience. In fact, over two-thirds (67%) of European IT leaders say their security teams feel under pressure to provide convenient access to applications and cloud services for users, but still maintain security – an indication they’re struggling to balance their digital transformation and security priorities. To this end, 96% believe that strong authentication and access management solutions can facilitate secure cloud adoption. Over three-quarters (76%) also revealed employee authentication needs to be able to support secure access to a broad range of services including virtual private networks and cloud applications.
Making small improvements
While some organisations still rely on legacy authentication methods like usernames and passwords, growing awareness of the threats is prompting action with almost all (94%) organizations having changed their security policies around access management in the last 12 months. Staff training on security and access management (47%), increasing spend on access management (43%), and access management becoming a board priority (37%), have all seen an increased focus. This is set to pay off in compliance terms too, with nearly all (98%) European respondents admitting controlling who has access to their company’s data. This will help them meet data regulation requirements like GDPR.
“As more and more businesses move to adopt cloud-based services for CRM, email, employee collaboration and IT infrastructure as part of their digital transformation strategies, the struggle to extend old solutions, designed to protect internal resources, to the outside world becomes very problematic. Often, in an effort to adapt to the new working habits of users connecting from anywhere, which is increasingly pertinent right now and will become standard moving forward, businesses tend to revert back to old password-based logins for cloud services in despair. This is knowingly increasing their security exposure to credential stuffing and phishing attacks,” said Francois Lasnier, Vice President for Access Management solutions at Thales.
Two steps forward, one step back
Looking ahead, some IT leaders are set to potentially use their influence at board level more wisely, with investment in the use of more secure methods such as biometric authentication (75%) and smart SSO (81%) set to increase in the next year. However, a third (67%) still plan to expand their use of usernames and passwords, which is a similar size to those intending to further utilise passwordless authentication methods (70%).
“For a long time, the biggest battle IT leaders have faced is increasing board awareness around taking the threat of security seriously,” Lasnier continued. “Now that they have that buy in, the focus should be on highlighting the importance access management plays in implementing a zero trust security policy to their executive management. With this in place, risk management professionals will be able to put in place a ‘Protect Everywhere - Trust Nobody’ approach as they expand in the cloud.”
1 The 2020 Access Management Index, is a survey of 400 executives in 7 countries in Europe and the Middle East with responsibility for, or influence over, IT and data security. The survey, reporting and analysis was conducted by Vanson Bourne , commissioned by Thales.
About Thales
Thales (Euronext Paris: HO) is a global technology leader shaping the world of tomorrow today. The Group provides solutions, services and products to customers in the aeronautics, space, transport, digital identity and security, and defence markets. With 80,000 employees in 68 countries, Thales generated sales of €18.4 billion in 2019.
Thales is investing in particular in digital innovations — connectivity, Big Data, artificial intelligence and cybersecurity — technologies that support businesses, organisations and governments in their decisive moments.
PLEASE VISIT
Thales Group
Security
Download HD photos
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200505005035/en/
Contact information
PRESS CONTACT
Thales, Media Relations
Security
Constance Arnoux
+33 (0)1 57 77 91 58
constance.arnoux@thalesgroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
